Poseida Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Biotechnology
  • ISIN: US73730P1084
USD
9.50
-0.06 (-0.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Net Sales
71.75
25.97
28.14
25.00
9.35
20.01
10.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
71.75
25.97
28.14
25.00
9.35
20.01
10.34
Raw Material Cost
1.30
1.35
1.38
1.44
1.44
1.41
1.32
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.29
2.26
2.25
2.27
2.24
2.14
2.03
Selling and Distribution Expenses
10.09
12.18
9.80
8.86
8.09
8.68
11.81
Other Expenses
3.83
4.19
3.93
3.83
3.38
3.56
3.47
Total Expenditure (Excl Depreciation)
52.01
57.73
52.72
50.90
45.57
47.87
49.86
Operating Profit (PBDIT) excl Other Income
19.7
-31.8
-24.6
-25.9
-36.2
-27.9
-39.5
Other Income
2.83
2.64
2.56
2.83
6.79
2.54
2.70
Operating Profit (PBDIT)
23.87
-27.76
-20.64
-21.64
-27.99
-23.91
-35.49
Interest
2.29
2.26
2.25
2.27
2.24
2.14
2.03
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
70.45
24.62
26.76
23.56
7.91
18.61
9.02
Depreciation
1.30
1.35
1.38
1.44
1.44
1.41
1.32
Profit Before Tax
20.28
-31.37
-24.27
-25.35
-31.67
-27.46
-38.85
Tax
0.04
0.00
0.00
0.00
0.11
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.23
-31.37
-24.27
-25.35
-31.78
-27.46
-38.85
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.23
-31.37
-24.27
-25.35
-31.78
-27.46
-38.85
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.23
-31.37
-24.27
-25.35
-31.78
-27.46
-38.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
87.21
60.82
84.59
103.70
123.66
135.30
157.56
Earnings per share (EPS)
0.21
-0.32
-0.25
-0.27
-0.35
-0.32
-0.45
Diluted Earnings per share
0.21
-0.32
-0.25
-0.27
-0.35
-0.32
-0.45
Operating Profit Margin (Excl OI)
27.52%
-122.27%
-87.33%
-103.66%
-387.32%
-139.18%
-382.06%
Gross Profit Margin
30.07%
-115.59%
-81.35%
-95.66%
-323.21%
-130.16%
-362.79%
PAT Margin
28.2%
-120.78%
-86.26%
-101.42%
-339.8%
-137.19%
-375.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2024 is 175.77% vs -7.47% in Jun 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2024 is 164.33% vs -29.22% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2024 is 169.08% vs -31.03% in Jun 2024

stock-summary

Interest

QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024

Compare Quarterly Results Of Poseida Therapeutics, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
71.75
16.64
55.11
331.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
71.75
16.64
55.11
331.19%
Raw Material Cost
1.30
8.41
-7.11
-84.54%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.29
2.49
-0.20
-8.03%
Selling and Distribution Expenses
10.09
16.07
-5.98
-37.21%
Other Expenses
3.83
0.29
3.54
1,220.69%
Total Expenditure (Excl Depreciation)
52.01
29.91
22.10
73.89%
Operating Profit (PBDIT) excl Other Income
19.74
-13.27
33.01
248.76%
Other Income
2.83
0.30
2.53
843.33%
Operating Profit (PBDIT)
23.87
-11.17
35.04
313.70%
Interest
2.29
2.49
-0.20
-8.03%
Exceptional Items
0.00
-0.15
0.15
100.00%
Gross Profit (PBDT)
70.45
8.23
62.22
756.01%
Depreciation
1.30
1.80
-0.50
-27.78%
Profit Before Tax
20.28
-15.60
35.88
230.00%
Tax
0.04
0.05
-0.01
-20.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
20.23
-15.65
35.88
229.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
20.23
-15.65
35.88
229.27%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.23
-15.65
35.88
229.27%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
87.21
-5.89
93.10
1,580.65%
Earnings per share (EPS)
0.21
-0.32
0.53
165.62%
Diluted Earnings per share
0.21
-0.32
0.53
165.62%
Operating Profit Margin (Excl OI)
27.52%
-79.73%
0.00
107.25%
Gross Profit Margin
30.07%
-82.97%
0.00
113.04%
PAT Margin
28.20%
-94.07%
0.00
122.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.17 Million
in Sep 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2024 is 175.77% vs -7.47% in Jun 2024

stock-summary

YoY Growth in quarter ended Sep 2024 is 662.77% vs -91.92% in Sep 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.02 Million
in Sep 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2024 is 164.33% vs -29.22% in Jun 2024

stock-summary

YoY Growth in quarter ended Sep 2024 is 163.52% vs -145.17% in Sep 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.10 Million
in Sep 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2024 is 169.08% vs -31.03% in Jun 2024

stock-summary

YoY Growth in quarter ended Sep 2024 is 160.34% vs -147.61% in Sep 2023

Quarterly - Interest
Interest 0.23 Million
in Sep 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024

stock-summary

YoY Growth in quarter ended Sep 2024 is 4.55% vs 22.22% in Sep 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.52%
in Sep 2024

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024

stock-summary

YoY Growth in quarter ended Sep 2024 has improved from Sep 2023